{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:38:32Z","timestamp":1789843112669,"version":"4.0.1"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 109-2314-B-038-083"],"award-info":[{"award-number":["MOST 109-2314-B-038-083"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["108TMU-WFH-07 and 110TMU-WFH-04"],"award-info":[{"award-number":["108TMU-WFH-07 and 110TMU-WFH-04"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>The aim of the study was to assess the relationship between prolactin levels and sexual dysfunction in patients with schizophrenia who use olanzapine medication. The potential risk factors of hyperprolactinemia and sexual dysfunction were also investigated. Patients with schizophrenia undergoing olanzapine monotherapy were invited to participate in this cross-sectional study. The Arizona Sexual Experiences Scale (ASEX) and the Positive and Negative Syndrome Scale were used to evaluate subjective sexual dysfunction and psychopathology, respectively. Levels of prolactin and metabolic parameters were also measured. In total, 279 participants with schizophrenia were recruited. The overall incidences of hyperprolactinemia, sexual dysfunction, and metabolic syndrome were 51.6, 53.8, and 43.7%, respectively. Higher ASEX scores, higher insulin levels, female sex, and younger age were associated with hyperprolactinemia. Prolactin level was significantly correlated with ASEX score. Elevated prolactin levels, concomitant antidepressant, increased insulin resistance, longer illness duration, and female sex were associated with sexual dysfunction. Female participants recorded higher levels of sexual dysfunction than their male counterparts did, whereas male participants had comparatively lower prolactin levels and lower rates of spousal partnership. Hyperprolactinemia, metabolic syndrome, and sexual dysfunction are prevalent in patients with schizophrenia treated with olanzapine. Clinicians should maintain awareness of these problems and monitor them regularly with their patients.<\/jats:p>","DOI":"10.3389\/fphar.2021.718800","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T06:51:20Z","timestamp":1628146280000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["The Relationships Between Hyperprolactinemia, Metabolic Disturbance, and Sexual Dysfunction in Patients With Schizophrenia Under Olanzapine Treatment"],"prefix":"10.3389","volume":"12","author":[{"given":"Tzu-Hua","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Hsin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kah Kheng","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia Yi-An","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hsin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien-Yuan","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mong-Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1196\/annals.1314.041","article-title":"Sexual Dysfunction Associated with Neuroleptic-Induced Hyperprolactinemia Improves with Reduction in Prolactin Levels","volume":"1032","author":"Ahl","year":"2004","journal-title":"Ann. N. Y Acad. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000486000","article-title":"Metabolic Syndrome in Hyperprolactinemia","volume":"49","author":"Andersen","year":"2018","journal-title":"Front. Horm. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1472-6823-13-12","article-title":"Serum Prolactin Concentrations as Risk Factor of Metabolic Syndrome or Type 2 Diabetes?","volume":"13","author":"Balbach","year":"2013","journal-title":"BMC Endocr. Disord."},{"key":"B4","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3389\/fphar.2019.00846","article-title":"Olanzapine-Induced Hyperprolactinemia: Two Case Reports","volume":"10","author":"Barata","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1176\/appi.ps.201800403","article-title":"Deficits in Sexual Interest Among Adults with Schizophrenia: Another Look at an Old Problem","volume":"70","author":"Bianco","year":"2019","journal-title":"Ps"},{"key":"B6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2165\/00003088-199937030-00001","article-title":"Olanzapine","volume":"37","author":"Callaghan","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/jcp.0b013e3181a289cb","article-title":"Olanzapine Plasma Concentrations after Treatment with 10, 20, and 40 Mg\/d in Patients with Schizophrenia","volume":"29","author":"Citrome","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.psc.2016.04.006","article-title":"Sexual Dysfunction Due to Psychotropic Medications","volume":"39","author":"Clayton","year":"2016","journal-title":"Psychiatr. Clin. North America"},{"key":"B9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1749-6632.1990.tb16887.x","article-title":"Endocrinological Responses to 5-HT","volume":"600","author":"Cowen","year":"1990","journal-title":"Ann. NY Acad. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/s0306-4530(02)00113-0","article-title":"Sexual Dysfunction and Antipsychotic Treatment","volume":"28","author":"Cutler","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0175204","DOI":"10.1371\/journal.pone.0175204","article-title":"Association between Serum Prolactin Levels and Insulin Resistance in Non-diabetic Men","volume":"12","author":"Daimon","year":"2017","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/schbul\/sbv001","article-title":"The Facts about Sexual (Dys)function in Schizophrenia: an Overview of Clinically Relevant Findings","volume":"41","author":"De Boer","year":"2015","journal-title":"Schizophrenia Bull."},{"key":"B13","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1517\/14740338.2014.906579","article-title":"Second-generation and Newly Approved Antipsychotics, Serum Prolactin Levels and Sexual Dysfunctions: a Critical Literature Review","volume":"13","author":"De Hert","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0228648","DOI":"10.1371\/journal.pone.0228648","article-title":"Prolactin Response to Antipsychotics: An Inpatient Study","volume":"15","author":"Dehelean","year":"2020","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000489420","article-title":"The Impact of Metabolic Syndrome and its Components on Female Sexual Dysfunction: A Narrative Mini-Review","volume":"12","author":"Di Francesco","year":"2019","journal-title":"Curr. Urol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"109804","DOI":"10.1016\/j.pnpbp.2019.109804","article-title":"Sexual Dysfunctions in Schizophrenia: Beyond Antipsychotics. A Systematic Review","volume":"98","author":"Dumontaud","year":"2020","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12888-018-1738-3","article-title":"Assessment of Sexual Dysfunction and Associated Factors Among Patients with Schizophrenia in Ethiopia, 2017","volume":"18","author":"Fanta","year":"2018","journal-title":"BMC Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1017\/s0033291700036539","article-title":"Subjective Utility Ratings of Neuroleptics in Treating Schizophrenia","volume":"20","author":"Finn","year":"1990","journal-title":"Psychol. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.pnpbp.2009.11.022","article-title":"Sexual Dysfunction in Japanese Patients with Schizophrenia Treated with Antipsychotics","volume":"34","author":"Fujii","year":"2010","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e785","DOI":"10.1038\/tp.2016.50","article-title":"Dopamine-prolactin Pathway Potentially Contributes to the Schizophrenia and Type 2 Diabetes Comorbidity","volume":"6","author":"Gragnoli","year":"2016","journal-title":"Transl Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1007\/s00213-017-4730-6","article-title":"Antipsychotic-induced Hyperprolactinemia: Synthesis of World-wide Guidelines and Integrated Recommendations for Assessment, Management and Future Research","volume":"234","author":"Grigg","year":"2017","journal-title":"Psychopharmacology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1590\/s0101-60832002000600002","article-title":"Schizophrenia: Do Men and Women Suffer from the Same Disease?","volume":"29","author":"H\u00e4fner","year":"2002","journal-title":"Rev. Psiquiatr. Cl\u00edn."},{"key":"B23","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s40264-017-0543-0","article-title":"Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies","volume":"40","author":"Hirsch","year":"2017","journal-title":"Drug Saf."},{"key":"B24","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12888-019-2205-5","article-title":"Sexual Dysfunction in Chinese Rural Patients with Schizophrenia","volume":"19","author":"Huang","year":"2019","journal-title":"BMC Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/s0140-6736(19)31135-3","article-title":"Comparative Efficacy and Tolerability of 32 Oral Antipsychotics for the Acute Treatment of Adults with Multi-Episode Schizophrenia: a Systematic Review and Network Meta-Analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"The Lancet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"686924","DOI":"10.1155\/2011\/686924","article-title":"Sexual Dysfunction and Hyperprolactinemia in Male Psychotic Inpatients: a Cross-Sectional Study","volume":"2011","author":"Johnsen","year":"2011","journal-title":"Adv. Urol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.4088\/jcp.v64n1008","article-title":"High-dose Olanzapine and Prolactin Levels","volume":"64","author":"Karagianis","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophrenia Bull."},{"key":"B29","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/jsm.12246","article-title":"Remitted Male Schizophrenia Patients with Sexual Dysfunction","volume":"11","author":"Kheng Yee","year":"2014","journal-title":"J. Sex. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.pnpbp.2011.11.016","article-title":"Sexual Dysfunction and Hyperprolactinemia in Japanese Schizophrenic Patients Taking Antipsychotics","volume":"37","author":"Kikuchi","year":"2012","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/s0306-4530(02)00128-2","article-title":"Hyperprolactinemia in Response to Antipsychotic Drugs: Characterization across Comparative Clinical Trials","volume":"28","author":"Kinon","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/jcp.0b013e31817e63a5","article-title":"Standard and Higher Dose of Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder","volume":"28","author":"Kinon","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/hup.2489","article-title":"Factors Associated with Self-Rated Sexual Function in Korean Patients with Schizophrenia Receiving Risperidone Monotherapy","volume":"30","author":"Lee","year":"2015","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"B34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1743-6109.2004.10106.x","article-title":"Epidemiology\/risk Factors of Sexual Dysfunction","volume":"1","author":"Lewis","year":"2004","journal-title":"J. Sex. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.schres.2017.07.022","article-title":"Application of Plasma Levels of Olanzapine and N -Desmethyl-Olanzapine to Monitor Metabolic Parameters in Patients with Schizophrenia","volume":"193","author":"Lu","year":"2018","journal-title":"Schizophrenia Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.tem.2020.01.004","article-title":"Time for a New Perspective on Prolactin in Metabolism","volume":"31","author":"Macotela","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s40618-018-0872-6","article-title":"From Inflammation to Sexual Dysfunctions: a Journey through Diabetes, Obesity, and Metabolic Syndrome","volume":"41","author":"Maiorino","year":"2018","journal-title":"J. Endocrinol. Invest."},{"key":"B38","first-page":"217","article-title":"Sexual Dysfunction Factors in Patients with Schizophrenia Treated with Second Generation Antipsychotics: Not Only Prolactin","volume":"46","author":"Mart\u00edn","year":"2018","journal-title":"Actas Esp Psiquiatr"},{"key":"B39","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/bf00280883","article-title":"Homeostasis Model Assessment: Insulin Resistance and ?-cell Function from Fasting Plasma Glucose and Insulin Concentrations in Man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"B40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/009262300278623","article-title":"The Arizona Sexual Experience Scale (ASEX): Reliability and Validity","volume":"26","author":"Mcgahuey","year":"2000","journal-title":"J. Sex. Marital Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11154-012-9229-1","article-title":"Role of Insulin Resistance in Endothelial Dysfunction","volume":"14","author":"Muniyappa","year":"2013","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"B42","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1464-410x.2005.05348.x","article-title":"Sexual Behaviour and Dysfunction and Help-Seeking Patterns in Adults Aged 40-80 Years in the Urban Population of Asian Countries","volume":"95","author":"Nicolosi","year":"2005","journal-title":"BJU Int."},{"key":"B43","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12888-018-1827-3","article-title":"Hyperprolactinemia and Insulin Resistance in Drug Naive Patients with Early Onset First Episode Psychosis","volume":"18","author":"Petruzzelli","year":"2018","journal-title":"BMC Psychiatry"},{"key":"B44","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s40263-014-0157-3","article-title":"The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: a Comprehensive Review","volume":"28","author":"Peuskens","year":"2014","journal-title":"CNS Drugs"},{"key":"B45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13098-019-0469-z","article-title":"Evaluation of Sexual Dysfunction and Female Sexual Dysfunction Indicators in Women with Type 2 Diabetes: a Systematic Review and Meta-Analysis","volume":"11","author":"Rahmanian","year":"2019","journal-title":"Diabetology Metab. Syndr."},{"key":"B46","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/jcp.0000000000000539","article-title":"How Hyperprolactinemia Affects Sexual Function in Patients under Antipsychotic Treatment","volume":"36","author":"Rubio-Abadal","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/mou.0000000000000426","article-title":"Metabolic Syndrome and Sexual Dysfunction","volume":"27","author":"Schulster","year":"2017","journal-title":"Curr. Opin. Urol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/yic.0b013e328341e434","article-title":"A Meta-Analysis of Sexual Dysfunction in Psychiatric Patients Taking Antipsychotics","volume":"26","author":"Serretti","year":"2011","journal-title":"Int. Clin. Psychopharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ajp.2016.08.022","article-title":"Sexual Dysfunction Among Women with Schizophrenia-A Cross Sectional Study from India","volume":"24","author":"Simiyon","year":"2016","journal-title":"Asian J. Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/00004714-200204000-00002","article-title":"The Effects of Antipsychotic-Induced Hyperprolactinaemia on the Hypothalamic-Pituitary-Gonadal Axis","volume":"22","author":"Smith","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09638237.2019.1581333","article-title":"Sexual Dysfunction in Patients with Schizophrenia and Schizoaffective Disorder and its Association with Adherence to Antipsychotic Medication","volume":"29","author":"Souaiby","year":"2019","journal-title":"J. Ment. Health"},{"key":"B52","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/hup.1218","article-title":"Dose-dependent Effects of Olanzapine on QT Intervals and Plasma Prolactin Levels in Japanese Patients with Stable Schizophrenia","volume":"26","author":"Suzuki","year":"2011","journal-title":"Hum. Psychopharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/jcp.0000000000000142","article-title":"Lack of Effect of Risperidone or Olanzapine Dose Reduction on Metabolic Parameters, Prolactin, and Corrected QT Interval in Stable Patients with Schizophrenia","volume":"34","author":"Takeuchi","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.2337\/diacare.27.5.1182","article-title":"Can We Apply the National Cholesterol Education Program Adult Treatment Panel Definition of the Metabolic Syndrome to Asians?","volume":"27","author":"Tan","year":"2004","journal-title":"Diabetes Care"},{"key":"B55","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/cen.12086","article-title":"Sex Hormone Binding Globulin and Insulin Resistance","volume":"78","author":"Wallace","year":"2013","journal-title":"Clin. Endocrinol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.pnpbp.2010.02.014","article-title":"Gender-specific Prolactin Response to Antipsychotic Treatments with Risperidone and Olanzapine and its Relationship to Drug Concentrations in Patients with Acutely Exacerbated Schizophrenia","volume":"34","author":"Yasui-Furukori","year":"2010","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.jsxm.2020.03.005","article-title":"Is There an Association between Schizophrenia and Sexual Dysfunction in Both Sexes? A Systematic Review and Meta-Analysis","volume":"17","author":"Zhao","year":"2020","journal-title":"J. Sex. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.718800\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T06:51:23Z","timestamp":1628146283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.718800\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,5]]},"references-count":57,"alternative-id":["10.3389\/fphar.2021.718800"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.718800","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,5]]},"article-number":"718800"}}